University Hospital in Prague
Prague, Czechia
NCT Number: NCT00764712
A randomized trial to compare three insulin-titration protocols for tight glycemic control in surgical ICU: an absolute glucose (Matias) protocol, a relative glucose change (Bath) protocol, and an enhanced model predictive control algorithm (eMPC)
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Prague, Czechia
120 consecutive post-cardiac surgery patients randomized to the three protocols with a target glycemia range from 4.4 to 6.1 mmol/l. Intravenous insulin was administered continuously or in combination with insulin boluses (Matias protocol). Blood glucose was measured in 1-4 hour intervals as requested by protocols.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Insulin was was administered according to each protocol rules/suggestions into a central venous line as a continuous infusion (Bath and eMPC protocols) or as a combination of a continuous infusion and boluses (Matias protocol). A standard concentration of 50 IU of insulin in 50 ml of 0.9% NaCl was used. In all patients, infusion of 10% glucose solution was initiated upon admission to ICU with glucose dose of 2.5 g/kg of ideal body weight (height in centimetres minus 100) per hour and lasted for 18 hours, when normal oral food intake was started. In ventilated patients, the glucose infusion lasted for 48 hours, and then standard enteral nutrition was initiated.
Other names: Actrapid HM, Novo Nordisk, Baegsvard, Denmark
Time frame: ICU stay
Time frame: ICU stay
Looking for future studies?
Notify MeCharles University, Czech Republic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00910988
Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
St Louis, Missouri, United States
View Trial DetailsNCT06040905
Alzheimer Disease, Brain Diseases
Taichung, Taiwan
View Trial DetailsNCT07119658
Body Weight, Cardiovascular Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT07686939
Glucose Metabolism Disorders, Glycemic Control
Taizhou, Zhejiang, China
View Trial Details